Digital Therapeutics (DTx) is a rapidly growing area of Digital Health.
Gill Jennings & Every LLP's recent whitepaper explains how innovators can navigate the challenges to securing patent protection for software-based therapeutics in Europe.
Stay ahead in digital health IP strategy and access Jack Severs' full article here.
Based on research completed as part of a multi-year collaboration with Nokia Bell Labs, biomedical engineers at Duke University are developing a solution. Using a custom-built optical coherence tomography (OCT) imaging system together with artificial intelligence (AI) models grounded in…
Rare conditions in the ICU include both formally classified rare diseases and conditions that occur infrequently in critical care settings. These patients often face delayed diagnosis, limited specialist expertise and complex multisystem involvement, all of which contribute to poorer outcomes…